Gainers at Nasdaq: MeetMe Inc (NASDAQ:MEET), KEYW Holding Corp. (NASDAQ:KEYW), StemCells Inc (NASDAQ:STEM), Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), Lands’ End, Inc. (NASDAQ:LE)

MeetMe Inc (NASDAQ:MEET) was downgraded by analysts at TheStreet from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. MeetMe Inc (NASDAQ:MEET) net profit margin is -16.60% and weekly performance is 8.11%. On last trading day company shares ended up $2.00. Analysts mean target price for the company is $4.75. MeetMe Inc (NASDAQ:MEET) distance from 50-day simple moving average (SMA50) is -20.84%.

Hexis Cyber Solutions, Inc, a wholly-owned subsidiary of The KEYW Holding Corporation (Nasdaq:KEYW), announced that a leading U.S. government agency has taken an initial delivery of its next-generation threat investigation and automated malware removal solution, HawkEye G, to deliver advanced threat detection and automated malware removal. KEYW Holding Corp. (NASDAQ:KEYW) shares advanced 8.71% in last trading session and ended the day on $11.61. Gross Margin is 34.10% and its return on assets is 34.10%. KEYW Holding Corp. (NASDAQ:KEYW) quarterly performance is -44.08%.

StemCells Inc (NASDAQ:STEM) on May 22 announced that it has transplanted the Company’s proprietary HuCNS-SC(R) (purified human neural stem cells) into the first five patients in the final cohort of its 16-patient Phase I/II trial for geographic atrophy of age related macular degeneration (GA-AMD). Each of the eight patients in this second cohort will receive a dose of 1 million stem cells into the most affected eye. StemCells Inc (NASDAQ:STEM) shares moved up 7.69% in last trading session and was closed at $1.54, while trading in range of $1.43 – $1.55. StemCells Inc (NASDAQ:STEM) year to date (YTD) performance is 25.20%.

Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) announced that it has inked a deal with Prasco, LLC to introduce an authorized generic version of Testim (testosterone gel). Testim is approved for the treatment of patients who have low or no testosterone. Prasco, which possesses product inventory, has started shipping the authorized generic version of Testim. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) ended the last trading day at $21.62. Company weekly volatility is calculated as 4.82% and price to cash ratio as 14.19. Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) showed a positive weekly performance of 0.32%.

Lands’ End, Inc. (NASDAQ:LE) shares jumped almost 8% on Thursday after the clothing retailer, in its first quarterly report since being spun off from struggling Sears Holdings Corp. SHLD +0.44% in April, reported its first-quarter profit jumped 48% to $10.9 million, or 34 cents a share, from $7.34 million, or 23 cents, a year earlier. Sales climbed 3.6% to $330.5 million. Lands’ End, Inc. (NASDAQ:LE) weekly performance is 7.82%. On last trading day company shares ended up $28.81. Lands’ End, Inc. (NASDAQ:LE) distance from 50-day simple moving average (SMA50) is 5.01%.